Medtronic Gets Conditional FTC Nod On $43B Inversion Deal
Medtronic Inc. will break off Covidien PLC's drug-coated balloon catheter business to move forward with its $42.9 billion acquisition of the Ireland-based medical device maker, officially settling the Federal Trade Commission's...To view the full article, register now.
Already a subscriber? Click here to view full article